Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator

被引:124
作者
Kaufmann, K [1 ]
Thiel, G [1 ]
机构
[1] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany
关键词
EGF; EGF receptor; Egr-1; HaCaT; extracellular signal-regulated kinase; signal transduction; thrombin;
D O I
10.1002/jcb.10145
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The epidermal growth factor (EGF) receptor is highly expressed in HaCaT keratinocytes as shown by Western blotting. Stimulation of HaCaT cells with EGF, and also with the serine protease thrombin, induced DNA synthesis, measured by incorporation of 5-bromo-2'-deoxyuridine into the DNA of proliferating cells. Using antibodies directed against the active form of the EGF receptor, we show that in HaCaT cells ECF and thrombin triggered a rapid activation of the EGF receptor, followed by the phosphorylation and activation of the extracellular signal-regulated protein kinase (ERK). Moreover, EGF and thrombin induced a transient synthesis of the zinc finger transcriptional regulator Egr-1. Proliferation, activation of ERK, and biosynthesis of Egr-1 was completely inhibited in EGF or thrombin-treated HaCaT cells by the MAP kinase kinase inhibitor PD98059 and by AG1487, an EGF receptor-specific tyrosine kinase inhibitor. These data indicate that phosphorylation and activation of both the EGF receptor and ERK are essential for mitogenic signaling via EGF and thrombin. The synthesis of Egr-1 in HaCaT cells as a result of EGF or thrombin stimulation suggests that Egr-1 may be an important "late" part of the EGF and thrombin-initiated signaling cascades. We postulate that Egr-1 may function as a "third messenger" in keratinocytes connecting mitogenic stimulation with changes in gene transcription. J. Cell. Biochem. 85: 381 -391, 2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:381 / 391
页数:11
相关论文
共 51 条
[1]   Impaired prostate tumorigenesis in Egr1-deficient mice [J].
Abdulkadir, SA ;
Qu, ZC ;
Garabedian, E ;
Song, SK ;
Peters, TJ ;
Svaren, J ;
Carbone, JM ;
Naughton, CK ;
Catalona, WJ ;
Ackerman, JJH ;
Gordon, JI ;
Humphrey, PA ;
Milbrandt, J .
NATURE MEDICINE, 2001, 7 (01) :101-107
[2]   Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes [J].
Algermissen, B ;
Sitzmann, J ;
Nürnberg, W ;
Laubscher, JC ;
Henz, BM ;
Bauer, F .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (10) :488-495
[3]   Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells [J].
Balmanno, K ;
Cook, SJ .
ONCOGENE, 1999, 18 (20) :3085-3097
[4]   Egr-1 activates basic fibroblast growth factor transcription - Mechanistic implications for astrocyte proliferation [J].
Biesiada, E ;
Razandi, M ;
Levin, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18576-18581
[5]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[6]   Immunodetection of the Ligand-Activated Receptor for Epidermal Growth Factor [J].
Campos-Gonzalez, Roberto ;
Glenney, John R., Jr. .
GROWTH FACTORS, 1991, 4 (04) :305-316
[7]   Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) mediated by STAT1 [J].
Chin, YE ;
Kitagawa, M ;
Su, WCS ;
You, ZH ;
Iwamoto, Y ;
Fu, XY .
SCIENCE, 1996, 272 (5262) :719-722
[8]   How the protease thrombin talks to cells [J].
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11023-11027
[9]   Signal characteristics of G protein-transactivated EGF receptor [J].
Daub, H ;
Wallasch, C ;
Lankenau, A ;
Herrlich, A ;
Ullrich, A .
EMBO JOURNAL, 1997, 16 (23) :7032-7044
[10]   Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells [J].
Dirks, PB ;
Patel, K ;
Hubbard, SL ;
Ackerley, C ;
Hamel, PA ;
Rutka, JT .
ONCOGENE, 1997, 15 (17) :2037-2048